895 related articles for article (PubMed ID: 28094055)
21. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
[TBL] [Abstract][Full Text] [Related]
22. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
23. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
[TBL] [Abstract][Full Text] [Related]
24. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
[TBL] [Abstract][Full Text] [Related]
25. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
26. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
[TBL] [Abstract][Full Text] [Related]
27. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
Delacroix SE; Chapin BF; Chen JJ; Nogueras-Gonzalez GM; Tamboli P; Matin SF; Wood CG
J Urol; 2011 Oct; 186(4):1236-41. PubMed ID: 21849197
[TBL] [Abstract][Full Text] [Related]
28. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
29. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
30. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
31. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
[TBL] [Abstract][Full Text] [Related]
32. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
33. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
[TBL] [Abstract][Full Text] [Related]
34. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
Wei Y; Wang M; Jin Y; Zhou C; Lyu J
World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
[TBL] [Abstract][Full Text] [Related]
35. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
37. Reassessing the current TNM lymph node staging for renal cell carcinoma.
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
[TBL] [Abstract][Full Text] [Related]
38. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases.
Giberti C; Oneto F; Martorana G; Rovida S; Carmignani G
Eur Urol; 1997; 31(1):40-8. PubMed ID: 9032533
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
[TBL] [Abstract][Full Text] [Related]
40. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]